Clinical Staphylococcus aureus Isolate Negative for the Sa442 Fragment
The Sa442 DNA fragment, originally described by Martineau et al. (3) , is a popular DNA target for identification of Staphylococcus aureus by PCR (2) (3) (4) (5) (6) . Several PCR-based assays targeting this DNA fragment alone or in combination with a mecA PCR for identification of a methicillin-resistant S. aureus have been described (3, 4) . Apart from having been established as being unique for S. aureus, the Sa442 fragment has not been further characterized.
Recently, we cultured a coagulase-positive staphylococcal isolate (strain 550226) identified as S. aureus by standard procedures. However, this particular isolate had tested negative in two previously published Sa442 assays (3, 4) , suggesting that it was not S. aureus. Because of this ambiguous result, DNA sequence analysis of part of the 16S rRNA gene was performed. The obtained DNA sequence was identical and unique to S. aureus. Hence, we concluded that this strain was indeed S. aureus.
The fact that this strain tested negative in the Sa442 PCR could be the result of a sequence variation in the primer binding site(s) or a deletion of (part of) the corresponding gene from the genome. To our knowledge, this has not been reported before. In order to design another primer set to amplify the Sa442 fragment, we looked for flanking sequences in the S. aureus genome. Therefore, the nucleotide sequence of the Sa442 fragment was compared to genomic sequences of S. aureus by using BLAST analysis (1). Interestingly, we found that the first 256 nucleotides of the originally described fragment (containing the target for the previously described Sa442 assays) could be mapped to a hypothetical S. aureus gene coding for a protein with similarity to glutamate synthase whereas the last 190 nucleotides correspond to part of the S. aureus phosphomevalonate kinase gene (mvaK2) with a 4-bp overlap between the two parts. These two genes are located in different regions of the S. aureus chromosome, which implies that the original Sa442 fragment must have been a cloning artifact. A novel primer set was used to amplify a 920-bp fragment containing the first 256 nucleotides of the Sa442 fragment. The primer binding sites were chosen so as not to include sequence variations in the corresponding gene among three S. aureus genomes available in the public domain (N315, Mu50, and MW2). The sequences of the forward and reverse primer were 5Ј-TCGTTGTAGGCTTCCTGCTT-3Ј and 5Ј-C AACTGATCGACGAAACGAA-3Ј, respectively. We randomly tested 20 S. aureus isolates, including strain 550226. All isolates, with the exception of strain 550226, tested positive, indicating deletion of the whole or a major part of the corresponding gene in strain 550226.
Our results show that the use of a single gene-or DNA fragment-specific PCR for identification of microbial isolates may result in misidentification if one is not aware of caveats as described here. Moreover, a number of S. aureus isolates may have been misidentified in the past or the presence of S. aureus in a clinical sample may have been overlooked when identification was solely based on the Sa442 PCR assay.
